bioAffinity Technologies
BIAF
17 hedge funds and large institutions have $104K invested in bioAffinity Technologies in 2025 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 5 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
0% more funds holding
Funds holding: 17 → 17 (0)
0.07% less ownership
Funds ownership: 0.11% → 0.04% (-0.07%)
21% less capital invested
Capital invested by funds: $132K → $104K (-$28.3K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AF
Allworth Financial
Folsom,
California
|
+$20.5K |
| 2 |
SG
StoneX Group
New York
|
+$5.8K |
| 3 |
IA
IFP Advisors
Tampa,
Florida
|
+$3.81K |
| 4 |
SI
Sprott Inc
Toronto,
Ontario, Canada
|
+$3.81K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.58K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$51.9K |
| 2 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$5.87K |
| 3 |
VHAM
Van Hulzen Asset Management
El Dorado Hills,
California
|
-$4.16K |
| 4 |
HF
HRT Financial
New York
|
-$4K |
| 5 |
Barclays
London,
United Kingdom
|
-$827 |
BIAF Hedge Fund Activity: Q2 2025 in Review
17 of the 7,603 institutional investors tracked by Wall St. Rank reported a position in bioAffinity Technologies (BIAF) for Q2 2025, worth a combined $104K — down 21% from $132K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new BIAF positions and 5 closed out — a net gain of 1 holder — while 4 added to existing stakes and 3 trimmed.
The largest buyer was Allworth Financial, opening a new position worth an estimated $20.5K. The largest seller was Vanguard Group, cutting an estimated $51.9K.
- 17 institutional investors held bioAffinity Technologies (BIAF) as of Q2 2025, unchanged from Q1 2025.
- Funds reported $104K of bioAffinity Technologies stock for Q2 2025, down 21% quarter-over-quarter.
- 6 funds opened new bioAffinity Technologies positions in Q2 2025 and 5 closed out, a net change of +1 holder.
- The largest bioAffinity Technologies buyer in Q2 2025 was Allworth Financial, an estimated $20.5K added.
- The largest bioAffinity Technologies seller in Q2 2025 was Vanguard Group, an estimated $51.9K sold.
Based on aggregated 13F filings for Q2 2025.